108 related articles for article (PubMed ID: 36089330)
21. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.
Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF
Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190
[TBL] [Abstract][Full Text] [Related]
22. Role of Rel/NF-kappaB transcription factors in apoptosis of human hepatocellular carcinoma cells.
Chiao PJ; Na R; Niu J; Sclabas GM; Dong Q; Curley SA
Cancer; 2002 Oct; 95(8):1696-705. PubMed ID: 12365017
[TBL] [Abstract][Full Text] [Related]
23. SHP-1 Acts as a Tumor Suppressor in Hepatocarcinogenesis and HCC Progression.
Wen LZ; Ding K; Wang ZR; Ding CH; Lei SJ; Liu JP; Yin C; Hu PF; Ding J; Chen WS; Zhang X; Xie WF
Cancer Res; 2018 Aug; 78(16):4680-4691. PubMed ID: 29776962
[TBL] [Abstract][Full Text] [Related]
24. Phosphatidylinositol 3-kinase and NF-kappa B/Rel are at the divergence of CD40-mediated proliferation and survival pathways.
Andjelic S; Hsia C; Suzuki H; Kadowaki T; Koyasu S; Liou HC
J Immunol; 2000 Oct; 165(7):3860-7. PubMed ID: 11034392
[TBL] [Abstract][Full Text] [Related]
25. Oncogenic Akt-FOXO3 loop favors tumor-promoting modes and enhances oxidative damage-associated hepatocellular carcinogenesis.
Lu M; Hartmann D; Braren R; Gupta A; Wang B; Wang Y; Mogler C; Cheng Z; Wirth T; Friess H; Kleeff J; Hüser N; Sunami Y
BMC Cancer; 2019 Sep; 19(1):887. PubMed ID: 31488102
[TBL] [Abstract][Full Text] [Related]
26. Lack of gp130 expression in hepatocytes attenuates tumor progression in the DEN model.
Hatting M; Spannbauer M; Peng J; Al Masaoudi M; Sellge G; Nevzorova YA; Gassler N; Liedtke C; Cubero FJ; Trautwein C
Cell Death Dis; 2015 Mar; 6(3):e1667. PubMed ID: 25741592
[TBL] [Abstract][Full Text] [Related]
27. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
Chen X; Kandasamy K; Srivastava RK
Cancer Res; 2003 Mar; 63(5):1059-66. PubMed ID: 12615723
[TBL] [Abstract][Full Text] [Related]
28. Genome-wide analysis of gene expression in T cells to identify targets of the NF-kappa B transcription factor c-Rel.
Bunting K; Rao S; Hardy K; Woltring D; Denyer GS; Wang J; Gerondakis S; Shannon MF
J Immunol; 2007 Jun; 178(11):7097-109. PubMed ID: 17513759
[TBL] [Abstract][Full Text] [Related]
29. 7,12-dimethylbenz(a)anthracene treatment of a c-rel mouse mammary tumor cell line induces epithelial to mesenchymal transition via activation of nuclear factor-kappaB.
Shin SR; Sánchez-Velar N; Sherr DH; Sonenshein GE
Cancer Res; 2006 Mar; 66(5):2570-5. PubMed ID: 16510574
[TBL] [Abstract][Full Text] [Related]
30. EYA4 inhibits hepatocellular carcinoma growth and invasion by suppressing NF-κB-dependent RAP1 transactivation.
Mo SJ; Hou X; Hao XY; Cai JP; Liu X; Chen W; Chen D; Yin XY
Cancer Commun (Lond); 2018 Apr; 38(1):9. PubMed ID: 29764501
[TBL] [Abstract][Full Text] [Related]
31. The zinc finger protein Miz1 suppresses liver tumorigenesis by restricting hepatocyte-driven macrophage activation and inflammation.
Zhang W; Zhangyuan G; Wang F; Jin K; Shen H; Zhang L; Yuan X; Wang J; Zhang H; Yu W; Huang R; Xu X; Yin Y; Zhong G; Lin A; Sun B
Immunity; 2021 Jun; 54(6):1168-1185.e8. PubMed ID: 34038747
[TBL] [Abstract][Full Text] [Related]
32. Mice lacking NF-κB1 exhibit marked DNA damage responses and more severe gastric pathology in response to intraperitoneal tamoxifen administration.
Burkitt MD; Williams JM; Townsend T; Hough R; Duckworth CA; Pritchard DM
Cell Death Dis; 2017 Jul; 8(7):e2939. PubMed ID: 28726772
[TBL] [Abstract][Full Text] [Related]
33. c-Rel orchestrates energy-dependent epithelial and macrophage reprogramming in fibrosis.
Leslie J; Macia MG; Luli S; Worrell JC; Reilly WJ; Paish HL; Knox A; Barksby BS; Gee LM; Zaki MYW; Collins AL; Burgoyne RA; Cameron R; Bragg C; Xu X; Chung GW; Brown CDA; Blanchard AD; Nanthakumar CB; Karsdal M; Robinson SM; Manas DM; Sen G; French J; White SA; Murphy S; Trost M; Zakrzewski JL; Klein U; Schwabe RF; Mederacke I; Nixon C; Bird T; Teuwen LA; Schoonjans L; Carmeliet P; Mann J; Fisher AJ; Sheerin NS; Borthwick LA; Mann DA; Oakley F
Nat Metab; 2020 Nov; 2(11):1350-1367. PubMed ID: 33168981
[TBL] [Abstract][Full Text] [Related]
34. Astrocyte elevated gene-1 promotes hepatocarcinogenesis: novel insights from a mouse model.
Srivastava J; Siddiq A; Emdad L; Santhekadur PK; Chen D; Gredler R; Shen XN; Robertson CL; Dumur CI; Hylemon PB; Mukhopadhyay ND; Bhere D; Shah K; Ahmad R; Giashuddin S; Stafflinger J; Subler MA; Windle JJ; Fisher PB; Sarkar D
Hepatology; 2012 Nov; 56(5):1782-91. PubMed ID: 22689379
[TBL] [Abstract][Full Text] [Related]
35. SPTBN1 inhibits inflammatory responses and hepatocarcinogenesis via the stabilization of SOCS1 and downregulation of p65 in hepatocellular carcinoma.
Lin L; Chen S; Wang H; Gao B; Kallakury B; Bhuvaneshwar K; Cahn K; Gusev Y; Wang X; Wu Y; Marshall JL; Zhi X; He AR
Theranostics; 2021; 11(9):4232-4250. PubMed ID: 33754058
[No Abstract] [Full Text] [Related]
36. Aerobic glycolysis enhances HBx-initiated hepatocellular carcinogenesis via NF-κBp65/HK2 signalling.
Chen L; Lin X; Lei Y; Xu X; Zhou Q; Chen Y; Liu H; Jiang J; Yang Y; Zheng F; Wu B
J Exp Clin Cancer Res; 2022 Nov; 41(1):329. PubMed ID: 36411480
[TBL] [Abstract][Full Text] [Related]
37. Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation.
Sakurai T; Maeda S; Chang L; Karin M
Proc Natl Acad Sci U S A; 2006 Jul; 103(28):10544-51. PubMed ID: 16807293
[TBL] [Abstract][Full Text] [Related]
38. TAZ-induced Cybb contributes to liver tumor formation in non-alcoholic steatohepatitis.
Wang X; Zeldin S; Shi H; Zhu C; Saito Y; Corey KE; Osganian SA; Remotti HE; Verna EC; Pajvani UB; Schwabe RF; Tabas I
J Hepatol; 2022 Apr; 76(4):910-920. PubMed ID: 34902531
[TBL] [Abstract][Full Text] [Related]
39. Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma.
Xiao Y; Huang S; Qiu F; Ding X; Sun Y; Wei C; Hu X; Wei K; Long S; Xie L; Xun Y; Chen W; Zhang Z; Liu N; Xiang S
EBioMedicine; 2020 Jan; 51():102603. PubMed ID: 31901862
[TBL] [Abstract][Full Text] [Related]
40. β-catenin deficiency in hepatocytes aggravates hepatocarcinogenesis driven by oncogenic β-catenin and MET.
Liang Y; Feng Y; Zong M; Wei XF; Lee J; Feng Y; Li H; Yang GS; Wu ZJ; Fu XD; Feng GS
Hepatology; 2018 May; 67(5):1807-1822. PubMed ID: 29152756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
